Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
Reducing the Psychosocial Impact of the Covid-19 Pandemic on Workers of Assisted Living Facilities
Current recruitment status is unconfirmed.
In Sant Boi de LlobregatIslamic Trauma Healing: A Scalable, Community-based Program for War and Refugee Trauma
Current recruitment status is unconfirmed.
In BuraoA School Program for Children Exposed to Violence
Read the official source — NCT00260195This study assessed depression symptoms.
This study has finished and is no longer accepting participants.
In Los Angeles
A school-based cluster-randomised controlled trial to determine the effectiveness of Therapeutic Storytelling Intervention (TSI) in promoting young people's mental health and wellbeing
This study has finished and is no longer accepting participants.
In New ZealandA school-based randomised controlled trial investigating the effect of the universal mental health prevention program, OurFutures Mental Health, on mental health literacy and symptoms of depression and anxiety
This study ended early.
In Australia
A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer
This study has finished and is no longer accepting participants.
In SeattleThis study has finished and is no longer accepting participants.
In MiamiThis study has finished and is no longer accepting participants.
In IvanhoeOptimizing Chronic Illness Self-Management for Individuals With Schizophrenia
This study has finished and is no longer accepting participants.
In BaltimorePilot Test of a Self-Management Program for Completers of Trauma-Focused Therapy
This study has finished and is no longer accepting participants.
In MinneapolisShared Decision Making: Ein Kommunikationstraining für Patienten Mit Schizophrenie
This study has finished and is no longer accepting participants.
In MünchenResearchers compared Aripiprazole Low (2 mg/day), Aripiprazole Mid (6 - 12 mg/day) and Aripiprazole High (24 - 30 mg/day) to find out how the approaches affected psychotic symptoms in children with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Chubu RegionWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.